Dupilumab is Effective in Patients with Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype.
The Journal of Allergy and Clinical Immunology In Practice（2022）
Key words
Dupilumab,Type 2 inflammation,Allergic asthma phenotype,Exacerbations,Lung function
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined